Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review
Human prostate cancer cells, stained blue, shown under a microscope.Adobe
By Annalisa Merelli
May 14, 2026
Annalisa Merelli
Annalisa.Merelli@statnews.com
A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths from…
New study found screening can reduce deaths by 13% but that overdiagnosis and subsequent overtreatment remain concerns
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of…
Decision over routine PSA testing is due at end of this month, though some feel the supporting data is unclear
Offering blood tests to men aged 45 and 70 could mean around 820 a year have their cancer caught earlier
Fewer men are undergoing unnecessary biopsies, which can have harmful side-effects, report finds
